NEWS OF IMMINENT VACCINE GIVES MARKETS A SHOT IN THE ARM

The positive news announced by US pharmaceutical giant Pfizer, in collaboration with Germany’s BioNtech, last week gave a glimmer of hope and served as a catalyst for appreciation in stock markets. The preliminary trials of the vaccine, involving a cohort of 43,500 volunteers, demonstrated 90% protective efficacy against Covid-19. Some 50 million doses could be available by the end of the year. Several other vaccines are also in phrase-three trials, for example at Johnson & Johnson and Astra Zeneca, which is also encouraging. Over the past week, vaccine news has triggered a sharp bounce in tourism-related sectors, financial stocks and cyclicals. There is hope – even if, in the short term, new infection cases may dampen economic growth, with France and Italy particularly badly affected and the US seeing a peak in hospitalisations, which have shot up by 40% over the past two weeks.

The aftermath of the US election, now clearly won by Joe Biden, raises the prospect of a divided government and thus a continuation of business-friendly policies. So things could hardly be better for equities. In Congress, the Republicans will probably retain their Senate majority, even if everything is not yet decided in Georgia, with two positions outstanding. The upshot is therefore a clearer outlook on the political front. In addition, important announcements on monetary measures are also expected from the Federal Reserve.

Optimism prevails among investors as we kick off a new week. Although the coronavirus is still raging in many parts of the world, business and commerce have remained relatively free of shackles, with local services such as restaurants, bars, sports halls and some shops shut down but companies continuing more or less as before.

The historic trade agreement between 15 Asia-Pacific countries, including China, Japan, South Korea and Australia, has pleased investors. This area represents about 30% of the world economy and 2.2 billion consumers. Officially called the Regional Comprehensive Economic Partnership, this deal will add an estimated 0.2% GDP growth to members’ economies and, by extension, boost the world economy. In addition, the robust economic recovery in China and Japan is strengthening confidence. Japan exited its recession in the third quarter, reporting GDP growth of 5% relative to the prior quarter compared with the 4.4% expected. Though the economy is still performing well below pre-Covid levels, the news is still encouraging. Chinese manufacturing output expanded by 6.9% year-on-year in October and retail sales by 4.3%. Business investment rose by 1.8% over the first ten months of 2020.

If you have any questions please contact the office on (03) 9670 6070.